|
End-of-day quote
Korea S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 14,890.00 KRW | -4.12% |
|
-10.68% | -74.06% |
| 23/07 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 22/12 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
| Market Cap | 22TCr 17Cr 15Cr 14Cr 13Cr 23Cr 1.59TCr 24Cr 164.75Cr 66Cr 837.62Cr 63Cr 62Cr 2.64TCr | P/E 2024 * |
-
| P/E 2025 | -77.1x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 15Cr 14Cr 13Cr 11Cr 21Cr 1.45TCr 22Cr 149.59Cr 60Cr 760.53Cr 57Cr 56Cr 2.4TCr | EV / Sales 2024 * |
-
| EV / Sales 2025 | 36,55,59,272x |
| Free-Float |
79.07% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.12% | ||
| 1 week | -10.68% | ||
| Current month | -14.13% | ||
| 1 month | -14.13% | ||
| 3 months | +2.83% | ||
| 6 months | -59.92% | ||
| Current year | -74.06% |
| 1 week | 14,510 |  | 17,000 |
| 1 month | 13,200 | | 18,970 |
| Current year | 13,050 | | 63,500 |
| 1 year | 13,050 | | 74,900 |
| 3 years | 13,050 | | 74,900 |
| 5 years | 13,050 | | 74,900 |
| 10 years | 13,050 | | 74,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tae-Kyo Park
CEO | Chief Executive Officer | 66 | 01/04/2015 |
Young-Seok Seo
DFI | Director of Finance/CFO | 69 | 01/06/2019 |
Yo-Seop Yu
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Tae-Kyo Park
BRD | Director/Board Member | 66 | 01/04/2015 |
Yo-Seop Yu
BRD | Director/Board Member | 58 | 01/04/2021 |
Gyeong-Se Min
BRD | Director/Board Member | 65 | 01/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/07/25 | Buy | Founder | 10,000 | 0.0674% | ||
| 15/07/25 | Buy | Founder | 26,000 | 0.1751% | ||
| 28/05/25 | Free | 2,07,960 | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.12% | -10.68% | -75.14% | - | 17Cr | |
| -0.62% | -1.87% | +46.31% | +56.99% | 6.38TCr | |
| +0.35% | +3.20% | +14.92% | +84.55% | 5.64TCr | |
| +0.53% | +1.96% | +15.37% | +106.81% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.41TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.21TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.1TCr | |
| +3.27% | +47.96% | +112.67% | +96.48% | 3.49TCr | |
| +1.22% | -1.44% | +14.89% | +47.15% | 3.28TCr | |
| +0.89% | +20.55% | -42.03% | +373.03% | 2.47TCr | |
| Average | -0.11% | +6.03% | +35.56% | +206.32% | 3.95TCr | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.45% | +186.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.91T 2.18 1.95 1.79 1.63 3.04 206.81 3.1 21.4 8.59 108.79 8.17 8 343.07 | 2.3T 1.72 1.54 1.42 1.29 2.41 163.67 2.45 16.93 6.8 86.1 6.47 6.33 271.52 |
| Net income | -991.28Cr -74.32L -66.56L -61.23L -55.48L -1.04Cr -71Cr -1.06Cr -7.3Cr -2.93Cr -37Cr -2.79Cr -2.73Cr -117.07Cr | -1.06TCr -79.5L -71.2L -65.49L -59.34L -1.11Cr -75Cr -1.13Cr -7.81Cr -3.14Cr -40Cr -2.98Cr -2.92Cr -125.22Cr |
| Net Debt | -214.59Cr -16.09L -14.41L -13.25L -12.01L -22.45L -15Cr -22.87L -1.58Cr -63.45L -8.04Cr -60.38L -59.1L -25Cr | -2.06TCr -1.54Cr -1.38Cr -1.27Cr -1.15Cr -2.15Cr -146.55Cr -2.19Cr -15Cr -6.09Cr -77Cr -5.79Cr -5.67Cr -243.11Cr |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | ₩14,890.00 | -4.12% | 18,519 |
| 29/26/29 | ₩15,530.00 | -4.72% | 21,804 |
| 28/26/28 | ₩16,300.00 | +2.00% | 21,661 |
| 27/26/27 | ₩15,980.00 | -0.75% | 22,757 |
| 26/26/26 | ₩16,100.00 | -3.42% | 12,099 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A287840 Stock
Select your edition
All financial news and data tailored to specific country editions
